St. John's Wort in the Treatment of Raynaud's Phenomenon
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This trial will test the efficacy of St. John's Wort (SJW) as a supplement, in the treatment
of Raynaud's phenomenon (RP). The investigators are hypothesizing that taking SJW 300mg, 3
times a day will decrease the frequency, duration, and severity of RP attacks when compared
to placebo.
Patients with RP will answer questionnaires and self-evaluate their symptoms of RP as a
baseline. Then they will be assigned to either a treatment (will receive SJW capsules) or
placebo (will receive non-therapeutic capsules) group. They will be required to take their
capsules, self-evaluate their progress and be evaluated every two weeks in a clinic. The
treatment phase will last six weeks.
This trial will be conducted in a way to mimic the normal usage of natural products. Patients
will not be required to stop any current treatment for RP.